#U.S. Veterinarians Market Revenue Value | Explore Tumblr posts and blogs

market-insider · 2 years ago

Text

U.S. Veterinarians Market Positively Impacted By Tests And Veterinary Telehealth Services During COVID-19

The U.S. veterinarians market size is poised to reach USD 23.3 billion by 2030, expanding at a CAGR of 8.7% during the forecast period, as per a new report by Grand View Research, Inc. The rising cases of zoonotic and chronic diseases, increasing animal health expenditure, and growing pet health concerns are the key factors driving the market. An estimated total of around 132,138 professionals were actively involved in the veterinary profession in the U.S. Approximately 57% of the U.S. veterinarians were employed in private practices in 2020. This number is estimated to increase in the coming years, owing to a rise in demand for veterinary services.

Although the COVID-19 pandemic presented several challenges to the animal health industry, it highlighted the need to secure the health of pets as well as food animals. With containment measures such as lockdowns & movement restrictions, manufacturing companies and veterinary service providers were significantly affected. Animal disease surveillance and reporting activities, such as outbreak investigation & disease reporting, were also disrupted due to logistical issues. This included restrictions & constraints on access to farms & transport of samples and veterinary equipment & PPE kits during the pandemic.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Veterinarians Market Report

However, companies manufacturing products or providing services that helped ease the pandemic burden, such as COVID-19 tests and veterinary telehealth services, were positively impacted. Veterinary visits too plunged due to the pandemic. However, the numbers soon recovered as veterinary services were recognized as an essential service. The U.S. government also announced several financial stimulus packages, flexible norms, and guidelines to ensure business continuity.

The Coronavirus Response and Relief Supplemental Appropriations Act & the Coronavirus Aid, Relief, and Economic Security (CARES) Act came into force to provide rapid & direct economic assistance to workers, families, & small businesses, and to preserve jobs in the U.S. Among other provisions, this included the Paycheck Protection Program to assist small businesses. C4, or the fourth COVID-19 relief bill, passed by the U.S. Congress in December 2020, included additional relief measures. Key provisions of C4 included a simplified loan waiver of up to USD 150,000, applicable to most veterinary practices.

With the growing number of pet parents in the U.S. and adoption of pet insurance, demand for animal health services is rising amongst people. In 2020, about 3.45 million pets had insurance coverage across North America, as per the North American Pet Health Insurance Association. Out of these, 3.1 million pets were insured in the U.S. alone. The highest percentage of insured pets were found to reside in California, New York, and Florida.

Dogs were the most frequently insured pets as compared to cats.Among the many available career paths, a notable number of U.S. veterinarians pursue teaching and/or research careers as faculty, thus contributing to the significant revenue share of the academics segment. New graduates are also inclined to enter internships and residencies at private veterinary practices or veterinary medicine colleges.

#U.S. Veterinarians Market Size & Share #U.S. Veterinarians Market Latest Trends #U.S. Veterinarians Market Growth Forecast #COVID-19 Impacts On U.S. Veterinarians Market #U.S. Veterinarians Market Revenue Value

0 notes

marketresearchindia · 3 years ago

Text

Global Animal Drug Compounding market Grow at Stellar CAGR 6.01%, Growth Opportunities, Trends-Top Key Players and Industry Analysis: Ken Research

Buy Now

The global Animal Drug Compounding market was valued at 794.14 Million USD in 2020 and will grow with a CAGR of 6.01% from 2020 to 2027, based on HNY Research newly published report.

The prime objective of this report”Global and Regional Animal Drug Compounding Industry Status and Prospects Professional Market Research Report Standard Version 2021-2027” is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography (North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient. Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.

Request For Sample Reports : https://kenresearch.com/sample-report.php?Frmdetails=NDcwNzkx

By Market Verdors:

Triangle Compounding Pharmacy

Lorraines Pharmacy

Medisca

Diamondback Drugs

ESSENTIAL PHARMACY COMPOUNDING VET

By Types:

Anti-Infective Agents

Hormones and Substitutes

Anti-Inflammatory Agents

By Applications:

Veterinary Hospitals

Veterinary Clinics

Veterinary Diagnostic Centers

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

For More Information, refer to below link:-

Global Animal Drug Compounding market Research Report

Related Post-

Global and Regional Hydrolyzed Collagen Industry Status and Prospects Professional Market Research Report Standard Version

Global Surgical Fluid Disposal Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]

+91-9015378249

#globalanimaldrugmarket #globalanimaldrugmarketresearchreport

0 notes

marketresearchstrategy · 3 years ago

Text

Digital Radiography Industry Supply Chain Analysis, Growth Opportunities, Top Companies, Revenue Growth and Business Development Report by 2027

Reports and Data has recently published a new research report on Global Digital Radiography Market that covers current development scenario and emerging trends of the market. The research report provides a comprehensive assessment of the market size, market share, revenue growth, and provides a futuristic perspective about the market trends, growth factors, facts, and industry validated market data. The report applies advanced statistical tools such as Porter’s Five Forces analysis and SWOT analysis to shed light on the competitive landscape of the global Digital Radiography market. The report covers all the critical and essential information relating to the global Digital Radiography market which helps the readers and clients gain a thorough understanding of the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/287

The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.

Key Companies in the market include:

GE Healthcare

Siemens Healthcare

Philips Healthcare

Agfa HealthCare

Fujifilm

Angell Technology

Carestream Health

Wandong Medical

Hitachi

Mindray

Land Wind

Toshiba

Konica Minolta

DEXIS

Shimadzu

Source-Ray

Samsung

Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.

Market segment analysis:

Digital Radiography: Segmentation

CR Tech Digital X-Ray System

DR Tech Digital X-Ray System

By Application Type (Revenue, USD Million; Volume in Tons, 2017–2027)

Dental

Orthopedics

General Surgery

Veterinarian

Others

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/287

Regional analysis further covers a country-wise analysis to offer insights into key trends and demands in each major country that might affect the growth of the market in the region.

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Mexico

Germany

U.K.

Italy

France

BENELUX

Rest of Europe

China

India

Japan

South Korea

Rest of APAC

Brazil

Rest of LATAM

Saudi Arabia

A.E.

South Africa

Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/digital-radiography-market

Key Features of the Global Digital Radiography Market Report:

Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value

Identification and analysis of significant trends and factors driving revenue growth of the market

Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches

Assessment of each market segment along with their growth trends and market revenue contribution

Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/287

Thank you for reading our report. Customization of this report is available according to the client’s needs. Please get in touch with us to know more about the customization feature and our team will ensure the report is tailored as per your requirements.

Browse More Reports:-

Triacetin/Glyceral Triacetate Market Share

Customer Information System (CIS) Market Size

0 notes

your-dietician · 3 years ago

Text

Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets

New Post has been published on https://depression-md.com/signs-agreement-with-vetbiolix-for-development-of-piclidenoson-for-pets/

Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets

All pre-clinical, clinical, and regulatory development work to be conducted and financially covered by Vetbiolix

Veterinary market has potential for a shorter path to regulatory approval and product revenues

PETACH TIKVA, Israel, June 28, 2021–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced it has signed a development and commercialization agreement with Vetbiolix, a France-based veterinary biotech company, for the development of Piclidenoson for the treatment of osteoarthritis in companion animals including dogs and cats.

Vetbiolix will have the exclusive right to Piclidenoson in the veterinary osteoarthritis market for two years, during which time Vetbiolix will conduct proof-of-concept studies and cover all associated costs. If the studies yield positive data and Vetbiolix exercises its option to obtain the license from Can-Fite, then Vetbiolix will be obligated to pay Can-Fite upfront and milestone payments, in addition to royalties on sales upon regulatory approval for veterinary use.

The canine osteoarthritis market is projected to reach $3 billion by 2024. According to Grand View Research, the broader global companion animal health market is estimated at a value of $20 billion in 2021 and is expected to grow to $27 billion by 2028.

Current treatments for canine osteoarthritis include oral non-steroidal anti-inflammatory drugs (NSAIDs) which only treat symptoms and carry significant harmful side effects, and an injectable disease modifying osteoarthritis drug (DMOAD) that targets the progression of the disease. Piclidenoson, an oral drug that has a favorable safety profile in humans and in animal studies, offers a potentially safe and effective oral treatment for canine osteoarthritis.

“The veterinary market is a significant opportunity where our drugs may have an impact. Both the size of the market and the shorter timelines to regulatory approval have the potential to result in milestone and royalty revenues for Can-Fite. We believe Piclidenoson’s safety and efficacy data in over 1,000 humans, as well as preclinical data from small animals, indicate it may offer relief to the growing number of companion animals with osteoarthritis,” stated Can-Fite VP of Business Development, Dr. Sari Fishman.

Story continues

Matthieu Roquette, President at Vetbiolix commented, “The quality of preclinical and clinical data generated by Can-Fite on Piclidenoson and its pharmacological profile make this highly selective A3 Adenosine Receptor Agonist a drug candidate likely to meet the unmet veterinary medical need to date in the management of osteoarthritis pathology in dogs and cats. Moreover, the mechanism of action of Piclidenoson makes this product a strong candidate for a large spectrum of inflammatory disease indications affecting Pets. We are aiming to enter in veterinary regulatory development by the end of 2022 based on clinical proof of concept data we will generate within the next 12 months.”

In 2019, the U.S. Patent and Trademark Office issued to the Can-Fite patent #10,265,337 titled “Use of A3 Adenosine Receptor Agonist in Osteoarthritis Treatment” for Piclidenoson in the treatment of osteoarthritis in mammals.

About Vetbiolix

Vetbiolix develops innovative products for treatment and prevention of diseases affecting pets. As pharmaceutical and biotech companies research novel molecules and compounds for human medicine, tests in different species often reveal exciting possibilities for pets. Vetbiolix has developed a unique approach focused on turning this potential into innovative prescription medicines and care products for pets. To date, veterinarians have still few therapeutics and real preventive care products at their disposal that have been specifically developed and approved for pets. Along with a virtual VetBiotech organization, Vetbiolix exclusively focuses on clinical developments of prescription medicines, diagnostics, nutraceuticals and care products for pets, thanks to its qualified external R&D partners in Europe & the US. Vetbiolix is supported by the Eurasanté Bio-Incubator, the northern France health cluster ranked among the top 20 best European incubators fostering pharm/biotech start-up development (Labiotech.eu 2019).

About Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19. The Company’s lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis and a Phase II study in the treatment of moderate COVID-19. Can-Fite’s liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH). Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S. Food and Drug Administration. Namodenoson has also shown proof of concept to potentially treat other cancers including colon, prostate, and melanoma. CF602, the Company’s third drug candidate, has shown efficacy in the treatment of erectile dysfunction. These drugs have an excellent safety profile with experience in over 1,500 patients in clinical studies to date. For more information please visit: www.can-fite.com.

Forward-Looking Statements

This press release may contain forward-looking statements, about Can-Fite’s expectations, beliefs or intentions regarding, among other things, market risks and uncertainties, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, Can-Fite or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as “believe,” “expect,” “intend,” “plan,” “may,” “should” or “anticipate” or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by Can-Fite with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of Can-Fite’s authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause Can-Fite’s actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause Can-Fite’s actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: our history of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all; uncertainties of cash flows and inability to meet working capital needs; the impact of the COVID-19 pandemic; the initiation, timing, progress and results of our preclinical studies, clinical trials and other product candidate development efforts; our ability to advance our product candidates into clinical trials or to successfully complete our preclinical studies or clinical trials; our receipt of regulatory approvals for our product candidates, and the timing of other regulatory filings and approvals; the clinical development, commercialization and market acceptance of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and our ability to operate our business without infringing the intellectual property rights of others; competitive companies, technologies and our industry; statements as to the impact of the political and security situation in Israel on our business; and risks and other risk factors detailed in Can-Fite’s filings with the SEC and in its periodic filings with the TASE. In addition, Can-Fite operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. Can-Fite does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210628005218/en/

Contacts

Can-Fite BioPharma Motti Farbstein [email protected] +972-3-9241114

Source link

0 notes

healthcare-market · 4 years ago

Text

Veterinary Dentistry Instruments & Equipment Market : Value Chain, Stakeholder Analysis and Trends

Transparency Market Research (TMR) has published a new report titled, “Veterinary Dentistry Instruments & Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global veterinary dentistry instruments & equipment market was valued at US$ 312.9 Mn in 2017 and is projected to expand at a CAGR of 5.2% from 2018 to 2026. The report suggests that rise in awareness among pet owners about the oral health of their companion or farm animals is likely to spur demand for veterinary dentistry instruments & equipment during the forecast period from 2018 to 2026. North America and Europe are likely to account for significant shares of the global veterinary dentistry instruments & equipment market. This is attributed to introduction of technologically advanced veterinary dentistry instruments & equipment in these developed markets by key players. Wide distribution network of major players and increase in market penetration of emerging players are likely to boost the growth of the veterinary dentistry instruments & equipment market in Asia Pacific from 2018 to 2026.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28586

Rise in Per Capita Spending on Pet Care to Drive the Global Market

Improved understanding of the best practices of veterinary dentistry among veterinarians and efforts taken by various private and public organizations to set a standard for veterinary dentistry are the key factors fueling the growth of the global veterinary dentistry instruments & equipment market. The emotional bond developed between owners and their pets makes them seek a standard and quality care for the pets. According to Pet Secure, people in the U.S. spend around US$ 50 Bn on their pets per annum. According to the journal The Australian, pet owners in Australia spend on an average US$ 12 Bn per annum on their pets. The frequency of visits to veterinary clinics for regular check-up of pets has increased owing to significant rise in per capita spending on pets. This is likely to generate demand for sophisticated procedures in veterinary dentistry, which in turn is expected to propel the veterinary dentistry instruments & equipment market.

Request for Analysis of COVID19 Impact on Veterinary Dentistry Instruments & Equipment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=28586

Periodontal Therapy Equipment & Instrumentation to Witness Consistent Growth

The report offers detailed segmentation of the global veterinary dentistry instruments & equipment market. Based on equipment, the market has been classified into oral examination instrumentation, periodontal therapy equipment & instrumentation, tooth extraction instruments & equipment, and ancillary equipment. The periodontal therapy equipment & instrumentation segment is poised to account for leading share of the global market during the forecast period from 2018 to 2026. The segment is projected to account for market share of 30.0% in 2018, owing to technological advancements in dental scaling and dental imaging techniques. Increase in demand for ultrasonic scalers for animals that efficiently remove calculus and plaques in case of gums or soft tissue inflammation is a key factor likely to drive the scaling equipment sub-segment during the forecast period.

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=28586

Asia Pacific to Offer Highest Incremental Opportunity

In terms of revenue, North America accounted for significant share of the global veterinary dentistry instruments & equipment market in 2017. Increase in pet expenditure as pet owners in the U.S. and Canada treat their pets as a family members propels the veterinary dentistry instruments & equipment market in North America. Rise in the number of privately-owned veterinary clinics and increase in adoption of advanced dental imaging techniques by dental professionals in India and China fuel the growth of the veterinary dentistry instruments & equipment market in Asia Pacific. Geographical expansion of international players into this region through distribution and licensing agreements with local distributors & suppliers is anticipated to augment the veterinary dentistry instruments & equipment market in Asia Pacific from 2018 to 2026. Rapidly developing dental industry in Mexico and favorable international trade for veterinary dentistry equipment in Brazil increase pet expenditure in Latin America. This is one of the major factors likely to boost the growth of the market in Latin America from 2018 to 2026.

Buy now Veterinary Dentistry Instruments & Equipment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=28586&ltype=S

Players such as ACTEON Group, iM3Vet Pty Ltd., and Dentalaire International to Lead the Market

The report provides profiles of leading players operating in the global veterinary dentistry instruments & equipment market. These include ACTEON Group, iM3Vet Pty Ltd., Dentalaire International, MAI Animal Health, TECHNIK TECHNOLOGY Ltd., Jorgen Kruuse A/S, Dispomed Ltd., Integra LifeSciences Holdings Corporation, Henry Schein, Inc., and Patterson Companies, Inc. Expansion of veterinary dentistry instruments & equipment portfolio by acquiring the business segments of emerging players is a key strategy adopted by key players.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/global-customized-procedure-trays-market-to-grow-as-the-medical-industry-acquires-research-excellence-says-tmr-301210766.html

https://www.prnewswire.com/news-releases/technological-strides-in-bladder-scanners-market-help-clinicians-advance-care-for-patients-with-urinary-tract-infections-valuation-to-touch-mark-of-us-210-0-mn-by-2026-tmr-301213972.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Transparency Market Research, 90 Sate Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/

0 notes

newmarketplace · 4 years ago

Text

What Is The Probability Of Growth Of The Autogenous Vaccines Market With The Technology Between Forecast Years?

Vaccination of animals is an essential part of animal health management. It helps to boost the immune system and keep animals safe from various bacterial and viral infections. Autogenous vaccines are most preferred for animal vaccination purposes. Federal guidelines state that an autogenous vaccine is made from a bacterial or viral strain of the diseased animal. Products made from these strains can only be marketed by veterinarian or farm owners from where they were isolated.

Over the years, there has been growing demand for autogenous vaccines that are derived from bacterial strains, owing to their greater efficacy as compared to viral strains. Salmonella, Staphylococcus, Haemophilus, and Mycoplasma are some of the commonly used bacterial strains to develop autogenous bacterial vaccines. Growing prevalence of bacterial infections among animals, preference toward autogenous vaccines over antibiotics, and increased funding and support for international animal disease eradication are likely to upswing demand for autogenous bacterial vaccines over the coming years.

According to a revised report published by Persistence Market Research, the autogenous vaccines market was valued over US$ 116 Mn in 2020, and is predicted to witness an impressive CAGR of 5.5% over the forecast period (2021-2031).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/29491

Companies covered in Autogenous Vaccines Market Report

Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)

Phibro Animal Health

Elanco Animal Health

Ceva Santé Animale

ACE Laboratory Services (Apiam Animal Health)

Huvepharma, Inc.

AniCon Labor GmbH

Cambridge Technologies

Dyntec s. r. o

Hygieia Biological Laboratories

HIPRA

Vaxxinova

sanphar (ipeve)

Addison Biological Laboratory

Zoetis (PHARMAQ AS)

Barramundi Asia Pte Ltd.(UVAXX Asia)

Kennebec River Biosciences

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/29491

Key Takeaways from Market Study

By type of strain, bacterial autogenous vaccines are expected to contribute to more than 1/3 revenue share in the market.

By end user, livestock farming companies will lead by acquiring over 45% of market share. This sector has witnessed the most adoption of autogenous vaccines as compared to other end users.

Europe holds around half of the global market share.

Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.

COVID-19 outbreak in big economies is expected to negatively impact demand for autogenous vaccines owing to reduced healthcare center visits. Impact was also observed on vaccine production and transportation owing to travel restriction and lack of workforce at production centers.

The market in Thailand is projected to be the fastest-growing in the Asia Pacific region, and will expand at a CAGR above 5% through 2031.

The U.S. market holds a big portion of revenue, and its market share accounts for more than 90% in North America.

“Increasing preference for autogenous vaccines over antibiotics will catalyze market growth over the coming years,” says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/29491

Collaborations & Acquisitions Key Strategies amongst Market Players

Prominent players manufacturing autogenous vaccines are collectively increasing their product ranges through strategic initiatives such as acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour market growth over the forecast period.

For instance,

In September 2019, Agri Labs (Huvepharma, Inc.) established a new fermentation plant in Peshtera, Southern Bulgaria.

In May 2017, Elanco Animal Health opened a new manufacturing facility for autogenous poultry vaccines in Winslow, Maine.

Agreement to acquire Bayer AG‘s animal health business by Elanco Animal Health in August 2019 is one of the major acquisitions in this space. This strategic move will help Elanco Animal Health enhance its market position.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the autogenous vaccines market in its latest study, presenting historical demand assessment of 2016-2020 and projections for 2021-2031, on the basis of strain (bacterial strain and viral strain) and end user (veterinary research institutes, livestock farming companies, and veterinary clinics and hospitals), across the five key regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Persistence Market Research Address – 305 Broadway, 7th FloorNew York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – [email protected] Website – https://www.persistencemarketresearch.com

#Autogenous Vaccines Market Analysis #Autogenous Vaccines Market Demand #Autogenous Vaccines Market Development #Autogenous Vaccines Market Forecast #Autogenous Vaccines Market Revenue Share #Autogenous Vaccines Market Size

0 notes

reportsjournal · 4 years ago

Text

Digital Radiography Market Growing Trade Among Emerging Economies Opening New Opportunities (2020-2027)

The market report study titled ‘Global Digital Detector Arrays Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new projects, financial situations, constructive business strategies, and an outlook on the industry forecast. The report aims to provide an in-depth analysis of the market impacted by the current pandemic. The COID-19 crisis has dynamically changed the economic scenario on a global level. The report is updated with the latest COVID-19 incidence, economic landscape, and present and future impact of COVID-19 on the market.

The research report further studies the growth driving and restraining factors impacting the regional market and competitive landscape of the business sphere. The study also offers deeper insights into the challenges and hurdles the established companies and new entrants might face in the Digital Detector Arrays industry.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/287

Competitive Analysis of the Digital Detector Arrays Market:

The Digital Detector Arrays market is further segmented into key players operating in the Digital Detector Arrays industry. The major companies profiled in the report include GE Healthcare, Siemens Healthcare, Philips Healthcare, Agfa HealthCare, Fujifilm, Angell Technology, Carestream Health, Wandong Medical, Hitachi, Mindray. The Digital Detector Arrays market offers a detailed analysis of the product portfolio, key trends, applications, and a thorough value chain analysis. The report further covers strategic initiatives taken by each player in order to gain a footing in the market and expand their global reach. This includes mergers and acquisitions, product launches, joint ventures, collaborations, government deals, partnerships, and others.

Market Segmentation:

Based on Type, the market is segmented into:

CR Tech Digital X-Ray System

DR Tech Digital X-Ray System

Based on Application, the market is segmented into:

Dental

Orthopedics

General Surgery

Veterinarian

Others

The segmentation section offers pivotal insights into revenue generated as well as volume estimations for each product type and application. The report also offers projections about the product or application segment expected to dominate the market in the coming years. It also highlights the trends of the market and offers a granular assessment of the supply chain.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/global-north-america-europe-and-asia-pacific-south-america-middle-east-and-africa-digital-radiography-market-2017-forecast-to-2022

Regional Analysis:

The report analyzes the market spread across key regions of the world and offers an assessment of the regional market pertaining to the growth rate, sales channels, and revenue generation. Furthermore, the key regions are also assessed for production and consumption rate, import/export, revenue contribution, market share and size, and the market presence of the prominent players in each region.

Key regions analyzed in the report are:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Radical Highlights of the Report:

Valuable insights about the Global Digital Detector Arrays Market with regards to market size, market share, valuations, and growth rate

Provides an 8-year forecast for the years 2020-2027, considering 2017 and 2018 as historical years, 2019 as the base year, and 2027 as the forecast year

Extensive analysis of the technological advancements, government regulatory framework, along with recent R&D and product advancements

Growth analysis and projections until 2027

Statistical analysis of the prominent players of the market

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/287

Key Questions Answered by the Report:

What are the key driving factors of the Digital Detector Arrays industry?

Which segment and sub-segment are expected to show significant growth during the forecast period?

What will the market size and growth rate be throughout the forecast period?

Who are the prominent players of the Digital Detector Arrays industry?

What are the technological advancements and product developments taking place in the Digital Detector Arrays market?

Which region is expected to dominate the market in the coming years?

What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?

What are the key risk factors and challenges the companies will face in the market?

What factors are expected to hinder the growth of the Digital Detector Arrays industry?

Browse Related Reports –

Artificial Joints Market Size and Prediction by Leading Manufacturers According to Its Application and Types Till 2027

Vein Detained Needle Market Insights Research and Outlook 2020 to 2027

Thank you for reading our report. The report can be customized based on regional segmentation and leading players. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.

0 notes

globalmarketreports · 4 years ago

Text

Animal Feed Additives Market Size, Share, Demand, Analysis and Forecast Report to 2027

The global animal feed additives market was valued at USD 34.01 billion in 2019 and is expected to reach USD 48.21 billion by 2027, growing at a CAGR of 4.63% from 2020 to 2027.

Animal feed additives are the extra nutrients or drug for livestock. Feed additives consists amino acids, fatty acids, pharmaceuticals, steroidal compounds, vitamins, minerals, and fungal products. Animal feed is used for digestibility or intestinal health of animal, and to maintain hygiene of animal.

Request Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Animal-Feed-Additives-Market/request-sample

Market Dynamics

Growing consumption of meat as a source of protein around the world is expected to be a key factor driving the demand for animal feed additives. In addition, various disease outbreaks in livestock animals such as swine flu and foot & mouth diseases in the past decade has increased concern over meat quality and safety which further has prompted the use of feed additives.

North America feed additive market revenues were estimated to be USD 8,788.9 million in 2020 and are expected to grow at a CAGR of 4.68% from 2020 to 2027. Growing consumer shift for organic meat is expected to be a key challenge for the market over the next few years. The increase in global energy costs is fast becoming a major factor in feed production, impacting upon the costs of feed ingredients and manufacturing as well as delivery.

Based on Type, polyester segment accounted for the largest share of the Animal Feed Additives Market in 2019

The growing demand for meat, especially in developing regions, is expected to be a key driving factor for the growth of the amino acids market in the near future. Lysine, a major amino acid consumed worldwide as a feed additive, is essential for the growth of animals, especially swine and Farms.

Based on End use, Veterinarians segment holds largest revenue share for Animal Feed Additives Market in 2019

Veterinary Services assumes a significant job in perception, early recognition and treatment of infections in creatures so as to limit foodborne pathogens from entering the natural way of life. Developed countries such as in the United States, more than 66% of veterinarians work in private or corporate clinical work on, giving veterinary consideration to a changed scope of animal types. This would, in turn, establish healthy platform for the growth of this market segment

Drivers: Growing meat consumption around the globe will support the industry growth

Growing meat consumption around the world has been a major driver for animal feed additive demand. In addition, growing awareness regarding the benefits of feed additives coupled with recent outbreak of diseases has prompted increased consumption of additives in animal feed

Growing life expectancy, scarce availability of land and water resources for animal feed production and growing grain demand for food and ethanol production has resulted in the meat industry looking to optimize feed utilization. In addition, due to recent epidemic outbreaks, the quality of food has become an important issue in countries worldwide, especially in North America and Europe. The awareness among consumers preferring extrinsic quality attributes of meat has increased, affecting the meat market globally

Challenges: Strict regulations towards animal welfare and consumer safety

Due to the development of strict regulations towards animal welfare and consumer safety, the use of Antibiotic Growth Promoters (AGPs) has been banned in countries within the European Union since 2006 and in the U.S. since 2009. On the other hand, countries like Brazil and China do not yet have this ban completely enforced against the use of antibiotics as feed additives. Such disparities in regulations have an adverse effect on global meat trade, especially between developed and developing economies.

Global Animal Feed Additives Market Restraints

Government regulations and policies regarding use of antibiotics in animal feed is the major restraining factor which is expected to hinder the growth of global animal feed additives market growth. Also, volatile raw material prices as well as increase in veganism will affect the growth of global animal feed additives market growth. Also ban on antibiotics in Europe and in the U.S. is expected to open up the market for replacement products such as enzymes, acidifiers and amino acids. Moreover, overlapping demand for major grains such as wheat, maize and barley from other commercial applications of food and biofuel is also expected to hamper market growth over the forecast period

Global Animal Feed Additives Market Key players

Various key players are discussed in this report such as AFB International, Novozymes A/S, Novus, du Pont De Nemours and Company, Lesaffre, Nebraska Cultures, Inc, Lallemand inc, Cargil Incorporated, BASF SE, Elanco,Adisseo, and Alltech.

Global Animal Feed Additives Market Taxonomy

By Types

Anti-Oxidants

Antibiotics

Feed Enzymes

Feed Prebiotics

Vitamins

Minerals

Amino Acids

Fatty Acids

Essential Oils

Others

By End User

Farms

Households

Veterinarians

Zoos

Animal Shelters

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Browse Full Report Details @ https://qualiketresearch.com/reports-details/Animal-Feed-Additives-Market

About Us:-

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:-

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A

Email: [email protected]

Website: https://qualiketresearch.com

0 notes

fmireports2020 · 4 years ago

Text

Canine Arthritis Market Registering a Strong Growth by 2029

Canine Arthritis Treatment Analysis 2019-2029

A recent market study published by Future Market Insights (FMI) on the Canine Arthritis Treatment including global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the canine arthritis treatment, the growth prospects of the market are obtained with maximum precision.

Canine Arthritis Treatment: Segmentation

The global canine arthritis treatment is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Treatment

Non-steroidal anti-inflammatory Medications (NSAIDs)

Opioids

Stem Cell Therapy

Allogeneic Stem Cells

Autologous Stem Cells

Route of Administration

Oral

Injectable

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the canine arthritis treatment, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the canine arthritis treatment.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the canine arthritis treatment in this chapter, which will help them understand the basic information about the canine arthritis treatment.

To get the sample copy of report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3552

Chapter 03 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the canine arthritis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Market Context

This section includes premium insights such as regulatory scenario, disease epidemiology, industry view point and market evolution. This section helps readers understand the key factors associated with the canine arthritis treatment market.

Chapter 05 – Global Canine Arthritis Treatment Value Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the Canine Arthritis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical canine arthritis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Treatment

Based on treatment type, the canine arthritis treatment market is segmented into Non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell therapy. In this chapter, readers can find information about the key trends and developments in the canine arthritis treatment and market attractiveness analysis based on treatment.

Chapter 07 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Route of Administration

This chapter provides details about the canine arthritis treatment based on mode of administration, and has been classified into oral and injectable. In this chapter, readers can understand the market attractiveness analysis based on route of administration.

Chapter 08 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the canine arthritis treatment market based on distribution channel, and has been classified into veterinary hospitals and clinics, retail pharmacies, drug stores, and E-Commerce. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 09 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the canine arthritis treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 10 – North America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America canine arthritis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 11 – Latin America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the canine arthritis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 12 – Europe Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the canine arthritis treatment market based on its Distribution Channels in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-3552

Chapter 13 – Asia Pacific Excluding Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in the APEJ region.

Chapter 14 – Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in Japan.

Chapter 15 – MEA Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the canine arthritis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 16 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the canine arthritis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco, Zoetis, Bayer, VetStem Biopharma and among others.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the canine arthritis treatment report.

Chapter 18 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about The Canine Arthritis Treatment.

Sources and Primary Research Splits (%)

Industry Interactions

Veterinarian

Marketing Directors

Product Managers

Business Development Officers

Production Managers

Sales Executives

Industry Experts

Current Market Dynamics and Challenges

Yesteryear Trends

Market Characteristics

Market Performance and Growth Quadrants

Strategic Growth Initiatives

Near-term and long-Term Market Growth Prospects

Market Segment Splits and Authenticity

Opinions on Market Projections and Validity of Assumptions

#Canine Arthritis Market

0 notes

jadhavsweety · 4 years ago

Text

COVID-19 Impact on Global Animal Feed Additives Market Growth By Manufacturers, Countries, Types And Application, End Users And Forecast To 2027

The global animal feed additives market was valued at USD 34.01 billion in 2019 and is expected to reach USD 48.21 billion by 2027, growing at a CAGR of 4.63% from 2020 to 2027.

Increase in meat consumption is expected to boost the global animal feed additives market growth. Furthermore, rise in industrial livestock production will have the positive impact on global animal feed additives market growth. Moreover, increase in developments in veterinary medicines is expected to global animal feed additives market growth. In other hand, growing nutritional deficiency in farm animals will raise the need for animal feed additives, which is expected to global feed additives market growth.

Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Animal-Feed-Additives-Market/request-sample

However, government regulations and policies regarding use of antibiotics in animal feed is the major restraining factor which is expected to hinder the growth of global animal feed additives market growth. Also, volatile raw material prices as well as increase in veganism will affect the growth of global animal feed additives market growth. Also ban on antibiotics in Europe and in the U.S. is expected to open up the market for replacement products such as enzymes, acidifiers and amino acids. Moreover, overlapping demand for major grains such as wheat, maize and barley from other commercial applications of food and biofuel is also expected to hamper market growth over the forecast period

Global Animal Feed Additives Market Segmentation

Global Animal Feed Additives Market is segmented into types such as Anti-Oxidants, Antibiotics, Feed Enzymes, Feed Prebiotics, Vitamins, Minerals, Amino Acids, Fatty Acids, Essential Oils, and Others, by end users such as Farms, Households, Veterinarians, Zoos, and Animal Shelters.

Also, Global Animal Feed Additives Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Global Animal Feed Additives Market Key players

By Types

Anti-Oxidants

Antibiotics

Feed Enzymes

Feed Prebiotics

Vitamins

Minerals

Amino Acids

Fatty Acids

Essential Oils

Others

By End User

Farms

Households

Veterinarians

Zoos

Animal Shelters

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Browse Full Research Report @ https://qualiketresearch.com/reports-details/Animal-Feed-Additives-Market

About Us

#Animal Feed Additives Market #Animal Feed Additives Market Trends #Animal Feed Additives Market Size #Animal Feed Additives Market Share

0 notes

your-dietician · 3 years ago

Text

Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets

New Post has been published on https://depression-md.com/can-fite-enters-projected-3-billion-veterinary-osteoarthritis-market-signs-agreement-with-vetbiolix-for-development-of-piclidenoson-for-pets/

Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets

PETACH TIKVA, Israel–(BUSINESS WIRE)– Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced it has signed a development and commercialization agreement with Vetbiolix, a France-based veterinary biotech company, for the development of Piclidenoson for the treatment of osteoarthritis in companion animals including dogs and cats.

About Vetbiolix

About Can-Fite BioPharma Ltd.

Forward-Looking Statements

View source version on businesswire.com: https://www.businesswire.com/news/home/20210628005218/en/

Source link

0 notes

floratraci · 4 years ago

Text

Global Veterinary Imaging Market

The global veterinary imaging market size was valued at USD 1.86 billion of every 2016 and is relied upon to develop at a CAGR of 6.6% during the figure time frame. Increase popular for veterinary diagnostics is required to fuel the interest as these devices are primarily utilized for maladies finding. Increase in incidence of zoonotic illnesses requests exact and compelling symptomatic tools, which is required to fuel the business development. Interest for viable solutions to improve livestock efficiency in developing economies is relied upon to drive the selection in coming years Developing consumption on animal health and pet protection are relied upon to contribute to increasing interest. Moreover, developing companion animal fragment because of high appropriation of pets and an increase in the number of vet practitioners around the globe are relied upon to propel the interest for these frameworks over the following years. The upsurge in the population of livestock, intense interest for dairy and meat products, ascend in the reception of pets, and increase in mindfulness among pet proprietors for better treatment choices for their pets are a portion of the elements foreseen to contribute to the development of the veterinary imaging market over the conjecture time frame. The instruments fragment accounted for the largest market share because of their developing interest. Imaging instruments are fundamental devices required inferable from which reception of these instruments is relied upon to increase over the gauge time frame. These instruments help in the identification of infections, cracks, and hemorrhages in animals. The interest in these instruments is foreseen to increase inferable from their increased affectability and low cost of activities. Radiography frameworks held a predominant offer starting in 2016. Vet practitioners look for digital radiography frameworks for whole-body imaging. Increasing mindfulness about dental consideration increases the interest for a redid digital scanner for taking high-resolution dental images, which is foreseen to fuel the development. Digital hardware has numerous advantages over traditional radiography X-beam frameworks as they help in lessening labor cost, time, and increasing net revenues of market players. These related advantages are ascribing toward its higher interest. Veterinary Picture Archiving and Communication System (PACS) are foreseen to observe lucrative CAGR attributable to the high appropriation of these frameworks in clinical settings. Increasing interest for frameworks with image sharing and data storage capabilities is contributing toward the section share. To address imaging issues of veterinarians, companies are concentrating on the development of cutting edge undertaking image seeing solutions. The small companion animals portion commanded in 2016 because of increased appropriation of pets as there has been increasing proof of people getting constructive health profits by their pets. Developing companion proprietorship has increased the interest for highly precise and successful symptomatic solutions, which is relied upon to propel the interest for imaging frameworks in the coming years. According to the American Pet Products Association, in 2016, approximately 35% of the households in the U.S. had felines and 44% had hounds. Around 85.8 million felines and 78 million mutts are claimed in the U.S. alone and this number is foreseen to increase over the figure time frame. Also, the increase in willingness to pay for pet health and availability of cost-compelling indicative solutions are variables contributing to the predominance of this portion. The large animal section is relied upon to observe enduring development as the interest for indicative imaging is increasing. Moreover, interest for noninvasive obtrusive analytic imaging frameworks coupled with an increase in the number of veterinary practitioners is a portion of the variables contributing to the section share. The other section includes extraordinary animals and oceanic species. This portion held smaller offer as an appropriation of these animals is lesser as compared to different sorts. Radiography, ultrasound, and CT imaging are a portion of the significant modalities utilized in the analysis of fascinating pets. Utilization of fitting radiographic projections, radiographic gear, and film-screen combinations upgrade analytic results. Orthopedic and traumatology applications accounted for the largest income share. Increase in wounds among animals, developing an interest for precise symptomatic solutions, and availability of animal consideration facilities are contributing to the predominance of this fragment starting at 2016. The neurology portion is foreseen to develop at a lucrative CAGR attributable to increasing incidence of common mind issue, for example, hydrocephalus, cerebrum malignant growth, ischemic infarcts (stroke), epilepsy, horrible mind wounds, and encephalitis. Reference laboratories are foreseen to observe lucrative CAGR. These laboratories offer comprehensive symptomatic tests for delivering effective results and consultation administrations of a specialist. Increase in collaborations between reference labs and companies for offering imaginative solutions to pet proprietors and an increase in promotional exercises for reference laboratories over the globe are a portion of the variables foreseen to propel section development. The others section is inclusive of purpose of-care facilities and scholastic and research foundations. This portion accounted for a smaller offer, as far as income, as these facilities commonly redistribute imaging administrations to hospitals or reference laboratories. It is relied upon to observe consistent development in the coming years inferable from the increase in research exercises in veterinary medication. The global market was commanded by developed districts, for example, North America and Europe. North American area caught almost 45% portion of the global market and is foreseen to keep up its strength over the conjecture time frame. Increase in R&D coupled with developing an interest for veterinary gear is foreseen to drive the development. This overwhelming offer can be ascribed to the development in pet appropriation coupled with increasing healthcare consumption in the animal health section. For example, according to the American Society for the Prevention of Cruelty to Animals, pet reception rate in North America has increased at a huge rate. Receive free sample copy of the report: http://99-report.com/sample/391-global-travel-insurance-market Asia Pacific regional market is relied upon to observe lucrative development because of rising healthcare use and increase in the enthusiasm of key players to invest in this market. Rising enthusiasm of companies to extend their essence in this area coupled with developing an interest for veterinary products is relied upon to drive the development. Likewise, increasing R&D, rising healthcare consumption in the veterinary field, and availability of low-cost animal health products are relied upon to drive the development. For example, products, for example, computed radiography and film-based radiography are available at lower costs in this locale as compared to developed districts, for example, North America and Europe. Likewise, government and nongovernment associations are taking activities to control the episode of zoonotic infections. The Asia Pacific Strategy for Emerging Diseases (APSED) was established with an expert to develop systems for the control and aversion of zoonotic maladies, which is foreseen to propel the reception. Nonetheless, low mindfulness coupled with lack of skilled veterinary professionals may hinder the development somewhat. The market is divided in nature the same number of small and large industry members are working in this area. A portion of the significant members in this industry is IDEXX Laboratories, Inc.; GE Healthcare; Sound; Carestream Health; and FUJIFILM Holdings America Corporation. Other market players are Esaote SpA; VetZ Limited; Hallmarq Veterinary Imaging Ltd; SUNI Medical Imaging, Inc.; and Universal Medical Systems, Inc. Producers are concentrating on R&D for creative technologies to pick up a competitive edge. Established players are investing in smaller companies for growing their appropriation channels and embracing techniques, for example, collaborations with local players and presentation of new products for increasing their foothold and catching a higher offer. For example, in June 2017, IDEXX Laboratories, Inc. collaborated with rVetLink, a referral management solution. This collaboration was planned to help in the extension of cloud technology products, which is foreseen to give imaginative and proficient administrations to its clients, accordingly contributing to development. To procure the report/gain in-depth insights, visit: http://99-report.com/report/391-global-travel-insurance-market

#Global Veterinary Imaging Market #Global Veterinary Imaging Market Size #North America Veterinary Imaging Market #Latin America Veterinary Imaging Market

0 notes

reportsjournal · 4 years ago

Text

Digital Detector Arrays Market Survey Research Report Added On Reports And Data

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/287

Competitive Analysis of the Digital Detector Arrays Market:

Market Segmentation:

Based on Type, the market is segmented into:

· CR Tech Digital X-Ray System

· DR Tech Digital X-Ray System

Based on Application, the market is segmented into:

· Dental

· Orthopedics

· General Surgery

· Veterinarian

· Others

Regional Analysis:

Key regions analyzed in the report are:

• North America (U.S., Canada)

• Europe (U.K., Italy, Germany, France, Rest of EU)

• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

• Latin America (Chile, Brazil, Argentina, Rest of Latin America)

• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Radical Highlights of the Report:

· Valuable insights about the Global Digital Detector Arrays Market with regards to market size, market share, valuations, and growth rate

· Provides an 8-year forecast for the years 2020-2027, considering 2017 and 2018 as historical years, 2019 as the base year, and 2027 as the forecast year

· Extensive analysis of the technological advancements, government regulatory framework, along with recent R&D and product advancements

· Growth analysis and projections until 2027

· Statistical analysis of the prominent players of the market

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/287

Key Questions Answered by the Report:

· What are the key driving factors of the Digital Detector Arrays industry?

· Which segment and sub-segment are expected to show significant growth during the forecast period?

· What will the market size and growth rate be throughout the forecast period?

· Who are the prominent players of the Digital Detector Arrays industry?

· What are the technological advancements and product developments taking place in the Digital Detector Arrays market?

· Which region is expected to dominate the market in the coming years?

· What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?

· What are the key risk factors and challenges the companies will face in the market?

· What factors are expected to hinder the growth of the Digital Detector Arrays industry?

Browse Related Reports –

Artificial Joints Market Size and Prediction by Leading Manufacturers According to Its Application and Types Till 2027

Vein Detained Needle Market Insights Research and Outlook 2020 to 2027

#Digital Detector Arrays Market #Digital Detector Arrays Market Size #Digital Detector Arrays Market Share #Digital Detector Arrays Market Growth #Digital Detector Arrays Market Demand #reports and data

0 notes

rohinic123-blog · 5 years ago

Text

Companion Animal Diagnostics Market to Witness Widespread Expansion by 2027

Transparency Market Research (TMR) has published a new report on the companion animal diagnostics market for the forecast period of 2019–2027. According to the report, the global companion animal diagnostics market was valued at ~US$ 2.3 Bn in 2018 and is projected to expand at a CAGR of ~9% from 2019 to 2027.

Global Companion Animal Diagnostics Market: Overview

Expansion of the global companion animal diagnostics market can be attributed to a rise in the incidence of obesity and other diseases in companion animals and increasing pet ownership.

North America dominated the global companion animal diagnostics market in 2018, and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early new product adoption, and presence of major market players are expected to drive the market in North America.

Asia Pacific is expected to be a highly lucrative market for companion animal diagnostics, expanding at a high CAGR during the forecast period.

Clinical biochemistry to Dominate Companion Animal Diagnostics Market

The clinical biochemistry segment dominated the global companion animal diagnostics market in 2018, and the trend is likely to continue during the forecast period. Clinical biochemistry tests refer to blood tests or lab tests that help gain information about the health of the companion animal. Clinical biochemistry also includes glucose analysis, electrolyte analysis and others. Increasing demand and popularity of chemistry analyzers and glucose monitoring devices in disease diagnosis drives the segment. Moreover, the high preference for various advanced clinical diagnostic products by veterinarians, pet owners, and laboratory technicians is likely to fuel the clinical biochemistry segment in the next few years.

Planning To Lay Down Future Strategy? Request Brochure Of Companion Animal Diagnostics Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66719

Companion Animal Diagnostics Market: Clinical Pathology to Offer Lucrative Opportunities

In terms of application, the global companion animal diagnostics market is divided into clinical pathology, bacteriology, parasitology, and others.

The clinical pathology segment includes cytopathology, hematology, clinical chemistry, immunohematology, coagulation, urinalysis, endocrinology, and general pathology. The clinical pathology segment dominated the global companion animal diagnostics market due to a rise in the demand for diagnostic products and consumables needed to be used during pathology testing, and an increase the number of pathology tests performed on pets.

Bacteriology is estimated to be a highly lucrative segment of the companion animal diagnostics market during the forecast period. Bacteriology refers to the diagnosis of various bacterial diseases and infection in companion animals. Bacteriology tests include bacterial pathogens testing in blood or serum samples, and aerobic and anaerobic culture testing.

Veterinary Reference Laboratories Account for Major Market Share

The veterinary reference laboratories segment dominated the global companion animal diagnostics market, in terms of revenue, in 2018. The trend is projected to continue during the forecast period. Increase in the number of veterinary reference laboratories across globe and availability of new advanced tests are likely to propel the segment. Furthermore, veterinary reference laboratories provide veterinary diagnostics to pet owners, and government-related programs or research collaborations are likely to boost the veterinary reference laboratories segment in the companion animal diagnostics market during the forecast period.

Veterinary hospitals and clinics is projected to be the second-most lucrative segment of the global companion animal diagnostics market during the forecast period. The segment is expected to expand at a significant CAGR from 2019 to 2027, as veterinary hospitals and clinics provide diverse veterinary diagnostic services for companion animals, and also provide advanced diagnosis testing.

North America to Dominate Global Companion Animal Diagnostics Market

North America accounted for a major share of the global companion animal diagnostics market in 2018, owing to an increase in pet ownership, pet insurance, and presence of major manufacturers in the region. According to North American Pet Health Insurance Association (NAPHIA) reports, the total number of pets insured in the U.S. and Canada reached 2.43 million at year-end 2018, an increase of 17% from 2017.

The companion animal diagnostics market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in the number of companion animals in countries such as China and Japan, improvement of healthcare infrastructure in terms of better facilities, and a rise in the demand for advanced products in the region.

To Obtain All-Inclusive Information On Forecast Analysis Of Companion Animal Diagnostics Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=66719

Global Companion Animal Diagnostics Market: Competitive Landscape

The global companion animal diagnostics market is fragmented in terms of number of players. Key players operating in the global companion animal diagnostics market include Heska Corporation, IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Zoetis, Inc., Neogen Corporation, bioMérieux SA, Randox Laboratories Ltd., and Virbac.

More Trending Reports by Transparency Market Research –

Digital Health Market –

https://www.prnewswire.com/news-releases/digital-health-market-to-attain-revenue-of-us536-6-billion-by-2025-due-to-growing-demand-for-advanced-devices-to-monitor-patients-says-tmr-300788873.html

N95 Mask Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76860

0 notes

medicaldevicetech · 5 years ago

Text

Veterinary Pain Management Market value 2020- global Industry Forecast to 2023

Market Insights

Technological Breakthroughs in Imaging to Bolster Global Veterinary Pain Management Market

Veterinary care is instrumental in alleviating the pain levels of companion and farm animals while tending to their injuries. Various drugs and treatments are administered to animals after considering the aftereffects as well as numerous risks. The global veterinary pain management market report by Market Research Future (MRFR) has compiled with a list of drivers, challenges, and opportunities being described in detail for comprehension of users.

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961

Market Outlook

The global Veterinary Pain Management Market Value is estimated to accrue significant revenue by exhibiting a CAGR of 8.2% during the forecast period (2018-2023). It acquired a unicorn valuation of USD 1000 million in 2017. Main factors driving market growth include adoption of pets, rise in preventive care treatment facilities and units for companion animals, and technologically imaging devices. Other major growth drivers include awareness campaigns by animal shelters and veterinarian organizations and pet insurance coverage schemes which can bolster the market demand.

The rise of nuclear families and rapid urbanization of cities are pushing the adoption rate of pets. Prevalence of various incurable diseases is expected to drive the veterinary pain management market to new heights due to various drugs designed to alleviate pain levels to a minimum. Investments in research and development to expedite the product to market combined with development of vaccines and drugs are contributing to market growth.

Regional Analysis

North America, Asia Pacific, Europe, and Rest-of-the-World (RoW) are the regions being considered for the basis of the report.

North America is estimated to hold the majority of the global veterinary pain management market due to rise in the adoption rate of pets in the U.S. and Canada. According to the survey by National Pet Owners, close to 68% of families owned household pets in the U.S. as of 2017. Other major drivers pushing the market expansion in the region include awareness of animal health, technically advanced devices, and preventive treatment facilities for companion animals. Investments in pet coverage schemes can bode well for the global veterinary pain management market in the forthcoming years.

Europe is the second biggest region for the market due to availability of advanced healthcare units and pet treatment clinics. Grading systems developing for assessing pain levels and doling out right advice are expected to drive regional market growth.

Competitive Outlook

Ceva Santé Animale, Elanco, Vetoquinol, Bayer, Assisi Animal Health, Zoetis, Merck Animal Health, Norbrook Laboratories, Boehringer Ingelheim, Dechra Pharmaceuticals, and Chanelle are major players of the global veterinary pain management market.

Segmentation Analysis

The global veterinary pain management market report is segmented by drug type, devices, route of administration, animal type, application, and end-user.

By drug type, it is segmented into nonsteroidal anti-inflammatory drugs (NSAID), opioids, local anesthetics, A2 adrenegic agonists, muscle relaxants, sedatives, and corticosteroids. Meloxicam, Fentanyl, and Etodolac are the branded drugs within in the NSAID segment. Opioids are further segmented into codeine, morphine, hydromorphone, and others. Lidocaine, Bupivacaine, chloroprocaine, and others are sub-segments of the local anesthetics segment. Xylazine, medetomidine, and others are A2 adrenegic agonists covered in the report.

By devices, it is segmented into electromagnetic therapy and laser therapy.

By route of administration, it is segmented into parenteral, oral, and topical.

By animal type, it is segmented into companion animals, livestock, exotic animals, research animals, aquatic animals, and zoo animals. Horses, cats, dogs, and others are animals discussed within the companion animals segment. On the other hand, poultry, cattle, and pigs are sub-segments within the livestock animals segment.

By application, it is segmented into joint pain, post-operative pain, and cancer. Joint pain is further divided into musculskeletal disorders and osteoarthritis.

By end-user, it is segmented into research institutes and universities, veterinary hospitals & clinics, and laboratories.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: [email protected]

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

#Veterinary Pain Management Market value

0 notes

shristipbi · 5 years ago

Text

Veterinary Vaccines Market Growth, Demand, Rising Trends and Forecast to 2025

Precision Business Insights (PBI) in its report titled “Global Veterinary Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over six years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global veterinary vaccines market was valued at US$ 3,354.2 Mn in 2018 and growing at a CAGR of 6.23% over the forecast period owing to increasing prevalence and incidence of livestock and zoonotic diseases coupled with rising expenditure on companion animals are expected to support the growth of the market. Moreover, increasing awareness in emerging countries regarding the animal health, advancements in technology and launch of new products (vaccines) in the veterinary market fuels the growth of the market. Additionally, government initiatives on animal health drives the market over the forecast years. However, high storage costs of vaccines and shortage of skilled veterinarians and skilled farm workers are anticipated to restrain the growth of the market over the forecast years.

Global veterinary vaccines market segmented on the basis of product, disease, species, and distribution channel

For request sample: https://www.precisionbusinessinsights.com/request-sample?product_id=16646

Attenuated Live Vaccines segment accounted for higher revenue share

Based on product type, global veterinary vaccines market segmented into attenuated live vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines segment market accounted US$ XX Mn in 2018 and projected to dominate over the forecast period due to easy administration and long-term immunity offered by live attenuated vaccines are factors driving the adoption of this technology.

North America is expected to grow at Highest CAGR in Global Veterinary Vaccines Market

PBI’s global veterinary vaccines market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America accounted for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to increasing pet adoption, launch of new products in the region and advancements in technology for the development of vaccines drives the growth of the market. Asia Pacific is expected to show highest growth over the forecast years owing to strategic decisions by the market players to expand their products in to the region due to increasing awareness among the people about the animal health and increasing investments in vaccines manufacturing facilities in the region fuels the growth of the market.

Strategic collaborations and acquisitions in Veterinary Vaccines Market

Global veterinary vaccines market further reveals that strategic collaborations and acquisitions for the development and innovation of new vaccine launches in the market to enhance market revenue share and gaining significant geographic presence across the region. For instance, in December 2017, Merck Animal Health acquired the Uruguay-based Prondil S.A. This acquisition helped Merck Animal Health develop more advanced vaccines for livestock animal in order to serve its customers.

Key player’s profiles in the report are Merial, Zoetis, Elanco, Merck & Co. Inc, Borhinger Ingelheim, Bayer Pharms Ag, Ceva, and Verbs.

Detailed Segmentation

By Product Type

o Attenuated Live Vaccines

o Inactivated Vaccines

o Subunit Vaccines

o Toxoid Vaccines

o DNA Vaccines

o Recombinant Vaccines

By Disease

o Anaplasmosis

o Canine Parvovirus

o Foot & Mouth Disease

o Newcastle Disease

o Distemper Disease

o Influenza Disease

o Porcine Reproductive & Respiratory Syndrome (PRRS) Disease

o Others

By Species

o Companion Animals

o Canine

o Avian

o Feline

o Livestock Animals

o Aquatic

o Bovine

o Porcine

o Ovine

o Poultry

o Others

By Distribution Channel

o Veterinary Hospitals & Clinics

o Veterinary Research Institutes

o Retail Pharmacies

Geography

o North America

· U.S

· Canada

o Europe

· Germany

· France

· U.K

· Italy

· Spain

· Russia

· Poland

· Rest of Europe

o Asia-Pacific

· Japan

· China

· India

· Australia & New Zealand

· ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

· South Korea

· Rest of Asia-Pacific

o Latin America

· Brazil

· Mexico

· Argentina

· Venezuela

· Rest of Latin America

o Middle East and Africa (MEA)

· Gulf Cooperation Council (GCC) Countries

· Israel

· South Africa

· Rest of MEA

For more information: https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

0 notes